Literature DB >> 2442502

The positive inotropic effect of felodipine in isovolumically beating dog heart.

K Pettersson, M I Noble, J A Björkman, J Hynd, A J Drake-Holland.   

Abstract

Felodipine is a potent arteriolar vasodilator. Its possible myocardial effects were studied by placing dogs anaesthetized with chloralose on cardiopulmonary bypass. A balloon was then inserted into the left ventricular cavity with a vent alongside it. Isovolumic contractions (developed pressure or maximal rate of rise of pressure) were studied as the intraventricular balloon was inflated to various levels. Total coronary venous return was collected to measure coronary blood flow and felodipine concentrations. In seven vagotomized and beta-blocked preparations, a small positive inotropic effect was found [32 +/- 11 (SEM)%, p less than 0.05]; the maximum effect was reached at arterial plasma felodipine concentrations of between 7 and 20 nM and was accompanied by appreciable coronary vasodilatation. In five dogs, infusion of the solvent vehicle (5% polyethylene glycol) alone had no effect. In three more dogs, an infusion of nitroprusside caused coronary vasodilatation, but no positive inotropic effect. The results show that at low concentrations, felodipine has a positive inotropic effect in vivo. These findings suggest that the properties of myocardial calcium agonist and vascular smooth muscle antagonist properties may coexist in the same dihydropyridine molecule. The favorable effects of this drug in the treatment of heart failure can be explained not only by reduction of peripheral resistance, but also by a moderate positive inotropic effect.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442502     DOI: 10.1097/00005344-198710001-00021

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

1.  Positive inotropic effects of calcium channel antagonists are not necessarily caused by partial calcium channel agonism.

Authors:  N C Punt; F T van Amsterdam; M M Goddijn; M Haas; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

Review 2.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

3.  Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion.

Authors:  E A Bernstein; F R Eberli; A M Silverman; G L Horowitz; C S Apstein
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

4.  Positive inotropic and negative chronotropic effects of (-)-cis-diltiazem in rat isolated atria.

Authors:  Y Nasa; K Ichihara; R Yoshida; Y Abiko
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  The effects of felodipine on left ventricular function in beta-blocked patients.

Authors:  A J Drake-Holland; S Pugh; C Mills; M I Noble
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Vascular versus myocardial effects of calcium antagonists.

Authors:  W C Little; C P Cheng
Journal:  Drugs       Date:  1994       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.